期刊文献+

ERβ重组质粒的构建及其在结肠癌细胞株Caco-2中的表达

Recombination of ERβ eukaryotic expression vector and its expression in Caco-2 cells
下载PDF
导出
摘要 目的:基因重组技术构建重组质粒pEGFP-C1-ERβ并检测其在结肠癌细胞株Caco-2中的表达.方法:应用RT-PCR从人结肠癌手术患者正常切缘组织中分离、扩增目的基因片段,将所得cDNA定向克隆到真核表达载体pEGFP-C1中,采用双酶切和测序分析鉴定插入基因的序列;脂质体介导重组质粒pEGFP-C1-ERβ瞬时转染Caco-2并上流式细胞仪分选,获得比较单一的转染细胞;分别采用RT-PCR、Western blot检测转染前后ERβ基因不同分子水平表达.结果:酶切鉴定和测序分析表明重组表达质粒pEGFP-C1-ERβ构建无误;RT-PCR和Western blot分析均表明,与转染空质粒pEGFP-C1组和空白对照组细胞相比,转染重组表达质粒pEGFP-C1-ERβ组细胞ERβ基因表达水平明显提高.结论:成功构建重组质粒pEGFP-C1-ERβ并在Caco-2细胞株中表达,为进一步研究ERβ如何通过雌激素受体通路调控下游靶基因表达和参与结肠癌表遗传学发生机制奠定了基础。 AIM: To construct the recombinant plasmid pEGFP-C1-ERβ with gene recombinant technique and detect its expression in Caco-2 cells. METHODS: ERβ gene in total RNA was isolated from human normal colon tissue of colorectal cancer patients and its segments were amplified by RT-PCR. The obtained cDNA was cloned into eukaryotic expression vector pEGFP-C1 to generate recombinant pEGFP-C1-ERβ. Sequence of the inserted gene was identified and analyzed after restriction enzyme digestion. Liposomemediated recombinant plasmid pEGFP-C1-ERβ was transfected into Caco-2 cells and identified by flow cytometry (FCM). RT-PCR and Western blot were used to detect expression of the ERβ gene at molecular level before and after transfection. RESULTS: Recombinant pEGFP-C1-ERβ was confirmed by restriction enzyme digestion and sequence analysis. The expression of Caco-2 cells transfected with pEGFP-C1-ERβ was higher than that of other controls. CONCLUSION: Recombinant pEGFP-C1-ERβ can be successfully constructed and expressed in Caco-2 cells, which lays a foundation for further study on ERβ gene in carcinogenesis by regulating the expression of down stream target gene through estrogenic hormone receptor.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第7期706-710,共5页 World Chinese Journal of Digestology
基金 国家自然科学基金资助课题资助项目 No.30500488~~
关键词 雌激素受体Β 基因重组 真核表达载体 结肠癌 Estrogenic hormone receptor β Gene recombination Eukaryotic expression vector Colon cancer
  • 相关文献

参考文献16

  • 1Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999, 106:574-582.
  • 2Crandall CJ. Estrogen replacement therapy and colon cancer: a clinical review. J Womens Health Gend Based Med 1999, 8:1155-1166.
  • 3Franceschi S, Gallus S, Talamini R, Tavani A, Negri E, La Vecchia C. Menopause and colorectal cancer. Br J Cancer 2000, 82:1860-1862.
  • 4Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 1999, 93:880-888.
  • 5Takeyama J, Suzuki T, Inoue S, Kaneko C, Nagura H, Harada N, Sasano H. Expression and cellular localization of estrogen receptors alpha and beta in the human fetus. J Clin Endocrinol Metab 2001, 86: 2258-2262.
  • 6Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic inucosa, but declines in colon adenocarcinoina paralleling the tuinour's dedifferentiation. Eur J Cancer 2003, 39: 1251-1258.
  • 7Wada-Hiraike O, Warner M, Gustafsson JA. New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans 2006, 34:1114-1116.
  • 8Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M, Gustafsson JA. Role of estrogen receptor beta in colonic epithelium.Proc Natl Acad Sci U S A 2006, 103:2959-2964.
  • 9Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001, 29:2905-2919.
  • 10Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001, 61:632-640.

二级参考文献11

  • 1Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA,1996, 93: 5925-5930.
  • 2Gustafsson JA, Warner M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J steroid Biochem Mol Biol, 2000. 74:245-248
  • 3Lazennec G, Bresson D, Lucas A, et al. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology, 2001, 142:4120-4130.
  • 4Roger P, Sahla ME, Makela S, et al. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.Cancer Res, 2001, 61:2537-2541.
  • 5Leygue E, Dotzlaw H, Watson PH, et al. Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res, 1998, 58:3197-3201.
  • 6Speirs V, Parkes AT, Kerin MJ, et al. Coexpression of estrogen receptor α and β: poor progonostic factors in human breast cancer? Cancer Res,1999, 59: 525-528.
  • 7Speirs V, Malone C, Walton DS, et al. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res, 1999, 59:5421-5424.
  • 8Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res, 2001, 29:2905-2919.
  • 9Cowley SM, Hoare S, Mosselman S, et al. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem, 1997, 272: 19858-19862.
  • 10Fan JD, Wagner BL, McDonnell DP. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol, 1996, 10:1605-1616.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部